Current treatment by United States and Canadian pediatric rheumatologists

Journal of Rheumatology

Volumn 26, Issue 9, 1999, Pages 2036-2038

  Cron, Randy Q ^a,b   Sharma, Seema ^a   Sherry, David D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pediatrics; Rheumatology; Treatment

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; SALAZOSULFAPYRIDINE;

ANAPHYLACTOID PURPURA; ARTHROPATHY; ARTICLE; CANADA; DERMATOMYOSITIS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RHEUMATOLOGY; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, JUVENILE RHEUMATOID; CANADA; CHILD; CHILD, PRESCHOOL; CLINICAL COMPETENCE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; METHOTREXATE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SULFASALAZINE; UNITED STATES;

EID: 0033432652     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dans LF, Dent PB. A survey of current prescribing practices in juvenile rheumatoid arthritis among pediatric rheumatologists in North America. Rev Bras Rheumatol 1995;35:263-9.
2. Mier R, Lovell D, Bowyer S, et al. Medication choices in juvenile rheumatoid arthritis. J Clin Rheumatol 1996;2:262-7.
3. Wallace CA, Levinson JE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin North Am 1991;17:891-905.
4. Giannini EH, Cawkwell GD. Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future. Pediatr Clin North Am 1995;42:1099-125.
5. Lehman TJA. Aggressive therapy for childhood rheumatic diseases. Arthritis Rheum 1993;36:71-4.
6. Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. J Rheumatol 1996;23:1968-74.
7. Weiss AH, Wallace CA, Sherry DD. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr 1998;133:266-8.
8. Hertzbergerten-Cate R, Cats A. Toxicity of sulfasalazine in systemic juvenile chronic arthritis. Clin Exp Rheumatol 1991;9:85-8.
9. Tozman EC, Gottlieb NL. Adverse reactions with oral and parenteral gold preparations. Med Toxicol 1987;2:177-89.
10. Giannini EH, Brewer EJ Jr, Kuzmina N, Shaikov A, Wallin B. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. Arthritis Rheum 1990;33:466-76.
11. Wallace CA. The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum 1998;41:381-91.
12. Pope JE. Treatment of systemic sclerosis. Rheum Dis Clin North Am 1996;22:893-907.
13. Remington PL, Shabino CL, McGee H, Preston G, Sarniak AP, Hall WN. Reye syndrome and juvenile rheumatoid arthritis in Michigan. Am J Dis Child 1985;139:870-2.
14. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulse doses of corticosteroids. Pediatrics 1996;128:146-9.
15. Szer IS. Henoch-Schönlein purpura: when and how to treat. J Rheumatol 1996;23:1661-5.